Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uhi Toh

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Cancer Science|June 5, 2020
Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancerUhi Toh, Sayaka Sakurai, Shuko Saku, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 21, 2024
[A Case of Late Recurrence of Breast Cancer with Gastric Metastasis 35 Years after Surgery]Yukiya Kishimoto, Ryou Yamanokuchi, Yoshihiro Uchino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 18, 2002
Intraarterial cellular immunotherapy for patients with inoperable liver metastases of esophageal cancerUhi Toh, Tomoya Sudo, Kouichiro Kido, et al.
Molecular Cancer Therapeutics|June 3, 2010
Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathwaysNaoko Seki, Uhi Toh, Thomas J Sayers, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2009
[A case of triple negative chest wall recurrent breast cancer treated with capecitabine and docetaxel combination therapy (XT therapy)]Yu Sawada, Teruhiko Fujii, Hiroki Takahashi, et al.
International Journal of Clinical Oncology|May 3, 2005
Advanced chemoresistant breast cancer responding to multidisciplinary treatment with hyperthermia, radiotherapy, and intraarterial infusionGoro Yokoyama, Teruhiko Fujii, Etsuyo Ogo, et al.
Digestive Surgery|May 22, 2003
Adjuvant chemotherapy after radical resection of squamous cell carcinoma in the thoracic esophagus: who benefits? A retrospective studyAnil Heroor, Hiromasa Fujita, Susumu Sueyoshi, et al.
The Kurume Medical Journal|January 19, 2012
Giant malignant phyllodes tumor: a case reportMiki Takenaka, Uhi Toh, Hiroko Otsuka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2003
[Autologous tumor specific immunotherapy of refractory cancers with ex vivo-generated T cells stimulated by autologous tumor cell]Uhi Toh, Hideaki Yamana, Kouichiro Kido, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 21, 2016
[Development of Peptide Vaccines for Triple-Negative Breast Cancer Treatment]Uhi Toh, Shuko Saku, Mina Okabe, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Cancer Science|June 5, 2020
Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancerUhi Toh, Sayaka Sakurai, Shuko Saku, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 21, 2024
[A Case of Late Recurrence of Breast Cancer with Gastric Metastasis 35 Years after Surgery]Yukiya Kishimoto, Ryou Yamanokuchi, Yoshihiro Uchino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 18, 2002
Intraarterial cellular immunotherapy for patients with inoperable liver metastases of esophageal cancerUhi Toh, Tomoya Sudo, Kouichiro Kido, et al.
Molecular Cancer Therapeutics|June 3, 2010
Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathwaysNaoko Seki, Uhi Toh, Thomas J Sayers, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2009
[A case of triple negative chest wall recurrent breast cancer treated with capecitabine and docetaxel combination therapy (XT therapy)]Yu Sawada, Teruhiko Fujii, Hiroki Takahashi, et al.
International Journal of Clinical Oncology|May 3, 2005
Advanced chemoresistant breast cancer responding to multidisciplinary treatment with hyperthermia, radiotherapy, and intraarterial infusionGoro Yokoyama, Teruhiko Fujii, Etsuyo Ogo, et al.
Digestive Surgery|May 22, 2003
Adjuvant chemotherapy after radical resection of squamous cell carcinoma in the thoracic esophagus: who benefits? A retrospective studyAnil Heroor, Hiromasa Fujita, Susumu Sueyoshi, et al.
The Kurume Medical Journal|January 19, 2012
Giant malignant phyllodes tumor: a case reportMiki Takenaka, Uhi Toh, Hiroko Otsuka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2003
[Autologous tumor specific immunotherapy of refractory cancers with ex vivo-generated T cells stimulated by autologous tumor cell]Uhi Toh, Hideaki Yamana, Kouichiro Kido, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 21, 2016
[Development of Peptide Vaccines for Triple-Negative Breast Cancer Treatment]Uhi Toh, Shuko Saku, Mina Okabe, et al.
Pageof 7